(OPRX) OPTIMIZERx - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US68401U2042

OPRX: Digital, Marketing, Solutions, Healthcare, Technology

OptimizeRx Corporation (NASDAQ: OPRX) is a digital health technology company that connects life sciences organizations, healthcare providers, and patients through a suite of tech-enabled marketing solutions. Its core platform leverages AI to generate dynamic audiences and activate real-time, data-driven campaigns. This platform allows clients to execute both traditional and dynamic marketing strategies, optimizing audience engagement during critical moments in patient care. By integrating with its proprietary digital point-of-care network, the company enhances the value of treatment information for healthcare professionals and patients, aligning marketing efforts with clinical care events. Founded in 2006, OptimizeRx operates from its headquarters in Waltham, Massachusetts.

Technical Analysis: OPRX is currently trading at $5.28, below its 20-day SMA of $5.69 and 50-day SMA of $5.42, but above its 200-day SMA of $7.56. The stock has shown recent volatility, with an ATR of 0.42, and averages 120,345 shares traded over the past 20 days.

Fundamental Analysis: The company has a market cap of $106.47 million, with a forward P/E of 16.29 and a price-to-book ratio of 1.00. Its price-to-sales ratio stands at 1.21, and the return on equity is -21.12%, indicating current profitability challenges.

3-Month Forecast: Based on the convergence of technical and fundamental data, OPRX is expected to experience modest volatility with potential upside driven by its forward P/E valuation. Support levels may form near $5.00, while resistance could emerge at $6.50. The stocks performance will likely hinge on its ability to demonstrate revenue growth and improve profitability metrics.

Additional Sources for OPRX Stock

OPRX Stock Overview

Market Cap in USD 143m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 1996-10-22

OPRX Stock Ratings

Growth 5y -32.4%
Fundamental -12.9%
Dividend 0.0%
Rel. Strength Industry -40.4
Analysts 4.29/5
Fair Price Momentum 6.05 USD
Fair Price DCF 2.73 USD

OPRX Dividends

No Dividends Paid

OPRX Growth Ratios

Growth Correlation 3m 31%
Growth Correlation 12m -89%
Growth Correlation 5y -63.5%
CAGR 5y 2.97%
CAGR/Max DD 5y 0.03
Sharpe Ratio 12m -1.39
Alpha -56.56
Beta 1.92
Volatility 185.43%
Current Volume 1073.2k
Average Volume 20d 120.5k
What is the price of OPRX stocks?
As of March 16, 2025, the stock is trading at USD 7.77 with a total of 1,073,240 shares traded.
Over the past week, the price has changed by +69.65%, over one month by +17.02%, over three months by +46.05% and over the past year by -39.86%.
Is OPTIMIZERx a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, OPTIMIZERx is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -12.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OPRX as of March 2025 is 6.05. This means that OPRX is currently overvalued and has a potential downside of -22.14%.
Is OPRX a buy, sell or hold?
OPTIMIZERx has received a consensus analysts rating of 4.29. Therefor, it is recommend to buy OPRX.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for OPRX stock price target?
According to ValueRays Forecast Model, OPRX OPTIMIZERx will be worth about 7 in March 2026. The stock is currently trading at 7.77. This means that the stock has a potential downside of -9.91%.
Issuer Forecast Upside
Wallstreet Target Price 9.7 25%
Analysts Target Price 9.6 24.1%
ValueRay Target Price 7 -9.9%